Accordingly, we analyzed IL-9 production of total lung cells from the three lung tumor regions after T cell stimulation with anti-CD3/CD28 antibodies in a cohort of NSCLC patients by ELISA (Figure 1H). This evidence concerns the gene IL9 and non-small cell lung carcinoma.